Meilleure Health International Industry Group Limited (HKG:2327)
Hong Kong · Delayed Price · Currency is HKD 0.2490
-0.0010 (-0.40%)
Jul 23, 2026, 3:58 PM HKT
HKG:2327 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,014 | 1,077 | 1,187 | 1,007 | 1,208 | 2,007 | |
Market Cap Growth | -9.26% | -9.28% | 17.89% | -16.63% | -39.81% | -5.10% |
Enterprise Value | 1,381 | 1,412 | 1,470 | 1,173 | 1,308 | 1,877 |
Last Close Price | 0.25 | 0.27 | 0.28 | 0.23 | 0.27 | 0.43 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 26.88 | 28.35 | 36.54 | 24.66 | 67.76 | 33.26 |
Forward PE | - | 10.74 | 10.74 | 10.74 | 10.74 | 10.74 |
PS Ratio | 27.76 | 29.48 | 23.42 | 7.79 | 10.07 | 7.93 |
PB Ratio | 0.81 | 0.86 | 0.99 | 0.80 | 0.91 | 1.40 |
P/TBV Ratio | 0.81 | 0.86 | 0.99 | 0.82 | 0.93 | 1.42 |
P/FCF Ratio | - | - | 6.39 | - | 28.66 | - |
P/OCF Ratio | - | - | 6.38 | - | 27.99 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 37.83 | 38.68 | 29.01 | 9.07 | 10.91 | 7.42 |
EV/EBITDA Ratio | - | - | - | 31.76 | 40.54 | 32.15 |
EV/EBIT Ratio | - | - | - | 33.15 | 42.41 | 32.73 |
EV/FCF Ratio | - | - | 7.91 | - | 31.03 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.31 | 0.31 | 0.25 | 0.24 | 0.19 | 0.12 |
Debt / EBITDA Ratio | - | - | - | 7.82 | 7.20 | 2.80 |
Debt / FCF Ratio | - | - | 1.63 | - | 5.91 | - |
Net Debt / Equity Ratio | 0.30 | 0.30 | 0.23 | 0.15 | 0.03 | -0.15 |
Net Debt / EBITDA Ratio | -40.99 | -40.99 | -102.48 | 5.17 | 1.18 | -3.60 |
Net Debt / FCF Ratio | -7.27 | -7.27 | 1.47 | -1.39 | 0.91 | 2.34 |
Asset Turnover | 0.02 | 0.02 | 0.03 | 0.08 | 0.07 | 0.15 |
Inventory Turnover | 0.04 | 0.04 | 0.09 | 0.20 | 0.20 | 0.56 |
Quick Ratio | 0.08 | 0.08 | 0.36 | 0.93 | 2.28 | 4.26 |
Current Ratio | 2.81 | 2.81 | 4.35 | 4.10 | 6.73 | 7.90 |
Return on Equity (ROE) | 3.10% | 3.10% | 2.61% | 2.98% | 1.29% | 4.27% |
Return on Assets (ROA) | -0.35% | -0.35% | -0.14% | 1.30% | 1.12% | 2.08% |
Return on Invested Capital (ROIC) | -0.60% | -0.63% | -0.19% | 1.83% | 1.67% | 3.24% |
Return on Capital Employed (ROCE) | -0.70% | -0.70% | -0.30% | 2.40% | 2.00% | 3.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.75% | 3.53% | 2.74% | 4.06% | 1.48% | 3.01% |
FCF Yield | -4.99% | -4.70% | 15.66% | -13.64% | 3.49% | -4.47% |
Dividend Yield | 2.20% | 2.08% | 1.41% | 1.70% | 6.03% | - |
Payout Ratio | 59.28% | 59.28% | 50.42% | 160.42% | - | - |
Buyback Yield / Dilution | 0.70% | 0.70% | 0.02% | 0.41% | 3.66% | 0.13% |
Total Shareholder Return | 2.90% | 2.78% | 1.43% | 2.11% | 9.69% | 0.13% |